NRXS: Record Q1 revenue and expanded coverage drive growth in pediatric and VA neuromodulation markets
Summary
NRXS reported record first-quarter revenue and strong gross margins. The company said expanded insurance coverage and a new Category 1 CPT code supported demand. It is concentrating commercial efforts on pediatric and VA markets. New hires and the resumed commercialization of the RED device are helping drive the growth story.
Classifications
industries
Fintech & Banking
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected